lodoxamide ethyl has been researched along with Keratoconjunctivitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gonzalez-Gonzalez, JM; Macias-Rodriguez, Y; Rodriguez-Garcia, A | 1 |
1 other study(ies) available for lodoxamide ethyl and Keratoconjunctivitis
Article | Year |
---|---|
Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
Topics: Administration, Topical; Adult; Aged; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Ophthalmic Solutions; Oxamic Acid; Prospective Studies; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Young Adult | 2018 |